FDA Drug Application (021241) for ORTHO TRI-CYCLEN LO by JANSSEN PHARMS

Back to FDA Applications sponsored by JANSSEN PHARMS

Application Number021241
Product Number001
FormTABLET;ORAL-28
Dosage0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameORTHO TRI-CYCLEN LO
Active IngredientETHINYL ESTRADIOL; NORGESTIMATE

Active IngredientCount
List of drugs with Active Ingredient ETHINYL ESTRADIOL226
List of drugs with Active Ingredient NORGESTIMATE23


Back to FDA Applications sponsored by JANSSEN PHARMS